Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Cangrelor is dosed at 0.5–1 mcg/kg/min IV Continuous IV infusion in dogs, per Source not established. The citation previously shown here named no retrievable document; a literature search on 2026-07-31 found no source that states this dose for this species and route. Treat as unverified and confirm against a primary reference before clinical use.. Cangrelor is used in dogs for Acute antiplatelet therapy (peri-procedural). Routes documented in dogs: IV. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Cangrelor in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Kengreal
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| IV | 0.5–1 mcg/kg/min | Continuous IV infusion | Short-term (hours); bridge until oral antiplatelet effective | Acute antiplatelet therapy (peri-procedural) | Extrapolated | Source not established. The citation previously shown here named no retrievable document; a literature search on 2026-07-31 found no source that states this dose for this species and route. Treat as unverified and confirm against a primary reference before clinical use. |
One of the cited rules is a continuous-rate-infusion regimen: IV 0.5–1 mcg/kg/min Continuous IV infusion. CRI regimens are delivered as a continuous infusion rather than discrete doses — verify the rate against the cited source before use.
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Direct-acting, reversible IV P2Y12 receptor antagonist that provides rapid, potent platelet inhibition with offset within 60 minutes of discontinuation.
Bleeding risk. Ultra-short acting — used when oral P2Y12 inhibitors cannot be given. Very limited veterinary data.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Cangrelor dose range in dogs, with cited source references: IV 0.5–1 mcg/kg/min Continuous IV infusion. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Cangrelor in dogs: IV.
Cited course lengths for Cangrelor in dogs include: Short-term (hours); bridge until oral antiplatelet effective. Duration depends on the indication — match it to the specific dose rule in the table above.
Cangrelor is indicated in dogs for: Acute antiplatelet therapy (peri-procedural).
These are general warnings for Cangrelor across species; consult the dog dosing table above for species-specific guidance. Bleeding risk. Ultra-short acting — used when oral P2Y12 inhibitors cannot be given. Very limited veterinary data.
Why a species-specific page? Cangrelor pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.